Boothbay Fund Management, LLC Pliant Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$16.48 - $28.98 $223,880 - $393,693	-13,585 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$28.05 - $37.69 $23,702 - $31,848	845 Added 6.63%	13,585 $396,000
Q1 2021 May 17, 2021	BUY	$24.52 - $40.23 $312,384 - $512,530	12,740 New	12,740 $501,000

158

63.8M

481K

105K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $609M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.